4.7 Article

Barrier-to-Autointegration Factor 1 Protects against a Basal cGAS-STING Response

期刊

MBIO
卷 11, 期 2, 页码 -

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/mBio.00136-20

关键词

interferon-stimulated gene; regulation; innate immunity; CRISPR; DNA virus; RNA virus; antiviral; interferon

资金

  1. NIH [R01 AI127774, R01AI145296, R01AI45828, R01 AI134035, R01 CA193318, R01 CA227001, P01 CA092584]
  2. American Cancer Society Research Scholar Award

向作者/读者索取更多资源

Although the pathogen recognition receptor pathways that activate cell-intrinsic antiviral responses are well delineated, less is known about how the host regulates this response to prevent sustained signaling and possible immune-mediated damage. Using a genome-wide CRISPR-Cas9 screening approach to identify host factors that modulate interferon-stimulated gene (ISG) expression, we identified the DNA binding protein Barrier-to-autointegration factor 1 (Banf1), a previously described inhibitor of retrovirus integration, as a modulator of basal cell-intrinsic immunity. Ablation of Banf1 by gene editing resulted in chromatin activation near host defense genes with associated increased expression of ISGs, including Oas2, Rsad2 (viperin), Ifit1, and ISG15. The phenotype in Banf1-deficient cells occurred through a cGAS-, STING-, and IRF3-dependent signaling axis, was associated with reduced infection of RNA and DNA viruses, and was reversed in Banf1 complemented cells. Confocal microscopy and biochemical studies revealed that a loss of Banf1 expression resulted in higher level of cytosolic double-stranded DNA at baseline. Our study identifies an undescribed role for Banf1 in regulating the levels of cytoplasmic DNA and cGAS-dependent ISG homeostasis and suggests possible therapeutic directions for promoting or inhibiting cell-intrinsic innate immune responses. IMPORTANCE Although the interferon (IFN) signaling pathway is a key host mechanism to restrict infection of a diverse range of viral pathogens, its unrestrained activity either at baseline or in the context of an immune response can result in host cell damage and injury. Here, we used a genome-wide CRISPR-Cas9 screen and identified the DNA binding protein Barrier-to-autointegration factor 1 (Banf1) as a modulator of basal cell-intrinsic immunity. A loss of Banf1 expression resulted in higher level of cytosolic double-stranded DNA at baseline, which triggered IFN-stimulated gene expression via a cGAS-STING-IRF3 axis that did not require type I IFN or STAT1 signaling. Our experiments define a regulatory network in which Banf1 limits basal inflammation by preventing self DNA accumulation in the cytosol.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results

Abby Sung, Adam L. Bailey, Henry B. Stewart, David McDonald, Meghan A. Wallace, Kate Peacock, Candace Miller, Kimberly A. Reske, Caroline A. O'Neil, Victoria J. Fraser, Michael S. Diamond, Carey-Ann D. Burnham, Hilary M. Babcock, Jennie H. Kwon

Summary: This study aimed to determine if SARS-CoV-2 virus can be recovered in viral cell culture from immunocompromised adults with persistently positive SARS-CoV-2 RT-PCR tests. Two patients with hematologic malignancies treated with chemotherapy and B cell depleting therapy showed positive viral cell cultures. Further research is needed to identify risk factors for persistent viral shedding and methods to prevent transmission from immunocompromised hosts.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Multidisciplinary Sciences

Standardized two-step testing of antibody activity in COVID-19 convalescent plasma

Pavlo Gilchuk, Isaac Thomsen, Sandra Yoder, Eric Brady, James D. Chappell, Laura J. Stevens, Mark R. Denison, Rachel E. Sutton, Rita E. Chen, Laura A. VanBlargan, Naveenchandra Suryadevara, Seth J. Zost, Jonathan Schmitz, Jill M. Pulley, Michael S. Diamond, Jillian P. Rhoads, Gordon R. Bernard, Wesley H. Self, Todd W. Rice, Allison P. Wheeler, James E. Crowe, Robert H. Carnahan

Summary: The COVID-19 pandemic has highlighted the urgent need for rapid evaluation of neutralizing antibody responses and the development of antibody-based treatments. The currently approved serological tests do not measure antibody-mediated viral neutralization, and there is a need for standardized quantitative neutralization assays. This study presents a high-throughput two-step profiling approach for identifying neutralizing convalescent plasma. Additionally, the researchers introduce a neutralizing antibody standard reagent to calibrate antibody neutralizing activity in convalescent plasma.

ISCIENCE (2022)

Article Biochemistry & Molecular Biology

Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice

Baoling Ying, Suzanne M. Scheaffer, Bradley Whitener, Chieh-Yu Liang, Oleksandr Dmytrenko, Samantha Mackin, Kai Wu, Diana Lee, Laura E. Avena, Zhenlu Chong, James Brett Case, LingZhi Ma, Thu T. M. Kim, Caralyn E. Sein, Angela Woods, Daniela Montes Berrueta, Gwo-Yu Chang, Guillaume Stewart-Jones, Isabella Renzi, Yen-Ting Lai, Agata Malinowski, Andrea Carfi, Sayda M. Elbashir, Darin K. Edwards, Larissa B. Thackray, Michael S. Diamond

Summary: The study showed that current vaccination can enhance protection against Omicron infections, but different vaccines have varying efficacy, which requires further investigation.
Review Immunology

Innate antiviral immunity: how prior exposures can guide future responses

Jeffrey A. Tomalka, Mehul S. Suthar, Michael S. Diamond, Rafick P. Sekaly

Summary: Innate immunity is an essential defense mechanism in cells, originating from bacteria and playing key roles in pathogen defense and immune response activation. Recent studies have shown that individual exposure histories, such as prior infections, vaccinations, and microbial metabolites, can modulate innate immunity and affect its effectiveness. Understanding how environmental factors regulate innate immune responses is crucial for pandemic preparedness.

TRENDS IN IMMUNOLOGY (2022)

Article Microbiology

A Multitrait Locus Regulates Sarbecovirus Pathogenesis

Alexandra Schafer, Sarah R. Leist, Lisa E. Gralinski, David R. Martinez, Emma S. Winkler, Kenichi Okuda, Padraig E. Hawkins, Kendra L. Gully, Rachel L. Graham, D. Trevor Scobey, Timothy A. Bell, Pablo Hock, Ginger D. Shaw, Jennifer F. Loome, Emily A. Madden, Elizabeth Anderson, Victoria K. Baxter, Sharon A. Taft-Benz, Mark R. Zweigart, Samantha R. May, Stephanie Dong, Matthew Clark, Darla R. Miller, Rachel M. Lynch, Mark T. Heise, Roland Tisch, Richard C. Boucher, Fernando Pardo Manuel de Villena, Stephanie A. Montgomery, Michael S. Diamond, Martin T. Ferris, Ralph S. Baric

Summary: Host genetic variation plays an important role in predicting disease outcomes following coronavirus infection. Using a mouse model, researchers identified several genetic loci that control different disease outcomes in the context of SARS-CoV infection. They also found a conserved locus on mouse chromosome 9 that shares homology with a human GWAS locus for severe SARS-CoV-2 disease. Two candidate genes, CCR9 and CXCR6, were identified as key regulators of disease severity in multiple coronavirus infections across species.
Article Multidisciplinary Sciences

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

James Brett Case, Samantha Mackin, John M. Errico, Zhenlu Chong, Emily A. Madden, Bradley Whitener, Barbara Guarino, Michael A. Schmid, Kim Rosenthal, Kuishu Ren, Ha Dang, Gyorgy Snell, Ana Jung, Lindsay Droit, Scott A. Handley, Peter J. Halfmann, Yoshihiro Kawaoka, James E. Crowe, Daved H. Fremont, Herbert W. Virgin, Yueh-Ming Loo, Mark T. Esser, Lisa A. Purcell, Davide Corti, Michael S. Diamond

Summary: SARS-CoV-2 Omicron variant strains are less susceptible to therapeutic neutralizing antibodies. However, therapeutic antibodies S309 and AZD7442 can still reduce lung infection in a mouse model. Different antibodies have different mechanisms of protection against Omicron variants.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice

Suzanne M. Scheaffer, Diana Lee, Bradley Whitener, Baoling Ying, Kai Wu, Chieh-Yu Liang, Hardik Jani, Philippa Martin, Nicholas J. Amato, Laura E. Avena, Daniela Montes Berrueta, Stephen D. Schmidt, Sijy O'Dell, Arshan Nasir, Gwo-Yu Chuang, Guillaume Stewart-Jones, Richard A. Koup, Nicole A. Doria-Rose, Andrea Carfi, Sayda M. Elbashir, Larissa B. Thackray, Darin K. Edwards, Michael S. Diamond

Summary: Bivalent vaccines induce broad immune responses against SARS-CoV-2 and its variants, offering a customizable approach to protect against COVID-19 as new strains emerge.

NATURE MEDICINE (2023)

Article Biochemistry & Molecular Biology

A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins

Vikas Chonira, Young D. Kwon, Jason Gorman, James Brett Case, Zhiqiang Ke, Rudo Simeon, Ryan G. Cosner, Darcy R. Harris, Adam S. Olia, Tyler Stephens, Lawrence Shapiro, Michael F. Bender, Hannah Boyd, I-Ting Teng, Yaroslav Tsybovsky, Florian Krammer, Ningyan Zhang, Michael S. Diamond, Peter D. Kwong, Zhiqiang An, Zhilei Chen

Summary: We report the engineering and selection of two synthetic proteins, FSR16m and FSR22, for the potential treatment of SARS-CoV-2 infection. These proteins exhibit broad-spectrum neutralization of SARS-CoV-2 strains and show promising results in mice, reducing viral burden and weight loss.

NATURE CHEMICAL BIOLOGY (2023)

Review Microbiology

A molecular understanding of alphavirus entry and antibody protection

Arthur S. Kim, Michael S. Diamond

Summary: This Review provides an overview of the global epidemics caused by arthropod-transmitted RNA viruses known as alphaviruses. It highlights the host factors required for alphavirus entry, the mechanisms by which protective antibodies inhibit alphavirus infection, and the progress of clinical evaluation of candidate vaccines focusing on humoral immunity.

NATURE REVIEWS MICROBIOLOGY (2023)

Article Cell Biology

Zika virus spreads through infection of lymph node-resident macrophages

Glennys Reynoso, David N. Gordon, Anurag Kalia, Cynthia C. Aguilar, Courtney S. Malo, Maya Aleshnick, Kimberly A. Dowd, Christian R. Cherry, John P. Shannon, Sophia M. Vrba, Autumn C. Holmes, Yael Alippe, Sonia Maciejewski, Kenichi Asano, Michael S. Diamond, Theodore C. Pierson, Heather D. Hickman

Summary: To understand the initial steps in Zika virus (ZIKV) transmission, researchers investigated the virus's movement from the skin to the lymph nodes. Contrary to previous beliefs, migratory immune cells were not necessary for the virus to reach the lymph nodes or the bloodstream. Instead, a specific subset of macrophages in the lymph nodes, called CD169+ macrophages, were found to be rapidly infected by ZIKV and release the virus to infect other lymph nodes. These findings improve our understanding of ZIKV dissemination and identify a potential target for antiviral intervention.

CELL REPORTS (2023)

Article Microbiology

Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2

Samantha R. Mackin, Pritesh Desai, Bradley M. Whitener, Courtney E. Karl, Meizi Liu, Ralph S. Baric, Darin K. Edwards, Taras M. Chicz, Ryan P. McNamara, Galit Alter, Michael S. Diamond

Summary: Fc-Fc gamma receptor interactions and alveolar macrophages play a crucial role in controlling infection with SARS-CoV-2 variants in mice vaccinated with ancestral vaccines. While the spike protein antigenic changes in SARS-CoV-2 variants reduce the neutralizing efficiency of legacy vaccine-induced antibodies, vaccines like mRNA-1273 and BNT162b2 still protect against severe disease and death, indicating the involvement of other aspects of immunity in controlling lung infection. Antibodies elicited by vaccines can bind Fc gamma receptors and exert effector functions against SARS-CoV-2 variants, and this property is associated with improved clinical outcomes. However, the causal relationship between Fc effector functions and vaccine-induced protection against infection needs further investigation.

NATURE MICROBIOLOGY (2023)

Article Immunology

Considering innate immune responses in SARS-CoV-2 infection and COVID-19

Michael S. Diamond, John D. Lambris, Jenny P. Ting, John S. Tsang

Summary: In early 2022, a workshop focusing on the innate immune response to SARS-CoV-2 was organized by staff from the NIAID at the NIH. This Viewpoint article features the thoughts of organizers and invited speakers on the key outcomes of the meeting. While the media has mainly focused on adaptive immunity during the COVID-19 pandemic, immunologists have been trying to understand how SARS-CoV-2 infection affects our innate immune system.

NATURE REVIEWS IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer

Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, Elad Binshtein, Rita E. Chen, James Brett Case, Kevin J. Kramer, Erica C. Armstrong, Luke Myers, Andrew Trivette, Christopher Gainza, Rachel S. Nargi, Christopher N. Selverian, Edgar Davidson, Benjamin J. Doranz, Summer M. Diaz, Laura S. Handal, Robert H. Carnahan, Michael S. Diamond, Ivelin S. Georgiev, James E. Crowe

Summary: This study identifies a rare human antibody, COV23434, that disrupts the integrity of the SARS-CoV-2 S protein and possesses a distinct class of functional activity. The findings suggest that the trimer interface region of the S protein may be a vulnerable site for the virus.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Biochemistry & Molecular Biology

Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo

George Georgiev, Ryan J. Malonis, Ariel S. Wirchnianski, Alex W. Wessel, Helen S. Jung, Sean M. Cahill, Elisabeth K. Nyakatura, Olivia Vergnolle, Kimberly A. Dowd, David Cowburn, Theodore C. Pierson, Michael S. Diamond, Jonathan R. Lai

Summary: Researchers have developed a recombinant ZIKV immunogen using protein engineering techniques, which can elicit a protective immune response with reduced potential for producing enhancing antibodies.

CELL CHEMICAL BIOLOGY (2022)

Meeting Abstract Allergy

Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination

Alexa Doss, Rita Chen, Jennifer Monroy, H. James Wedner, Anthony Kulczycki, Tiffany Dy, Zhen Ren, Andrew Kau, Tarisa Mantia, Caitlin O'Shaughnessy, Brandi Nickles, Peggy Kendall, Michael Diamond, Ofer Zimmerman

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

暂无数据